EYPT
Price
$6.68
Change
+$0.04 (+0.60%)
Updated
Apr 30, 12:45 PM (EDT)
Capitalization
456.36M
Earnings call today
LYRA
Price
$0.12
Change
-$0.00 (-0.00%)
Updated
Apr 30, 12:57 PM (EDT)
Capitalization
6.56M
13 days until earnings call
Ad is loading...

EYPT vs LYRA

Header iconEYPT vs LYRA Comparison
Open Charts EYPT vs LYRABanner chart's image
EyePoint Pharmaceuticals
Price$6.68
Change+$0.04 (+0.60%)
Volume$100
Capitalization456.36M
Lyra Therapeutics
Price$0.12
Change-$0.00 (-0.00%)
Volume$25K
Capitalization6.56M
EYPT vs LYRA Comparison Chart
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. LYRA commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and LYRA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (EYPT: $6.64 vs. LYRA: $0.12)
Brand notoriety: EYPT and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 48% vs. LYRA: 588%
Market capitalization -- EYPT: $456.36M vs. LYRA: $6.56M
EYPT [@Biotechnology] is valued at $456.36M. LYRA’s [@Biotechnology] market capitalization is $6.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 5 TA indicator(s) are bullish while LYRA’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 5 bullish, 5 bearish.
  • LYRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than EYPT.

Price Growth

EYPT (@Biotechnology) experienced а +2.08% price change this week, while LYRA (@Biotechnology) price change was +26.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.55%. For the same industry, the average monthly price growth was +2.15%, and the average quarterly price growth was -10.01%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($456M) has a higher market cap than LYRA($6.56M). EYPT YTD gains are higher at: -10.872 vs. LYRA (-42.829). LYRA has higher annual earnings (EBITDA): -60.26M vs. EYPT (-129.23M). EYPT has more cash in the bank: 371M vs. LYRA (40.6M). EYPT has less debt than LYRA: EYPT (21.9M) vs LYRA (34.4M). EYPT has higher revenues than LYRA: EYPT (43.3M) vs LYRA (1.53M).
EYPTLYRAEYPT / LYRA
Capitalization456M6.56M6,957%
EBITDA-129.23M-60.26M214%
Gain YTD-10.872-42.82925%
P/E RatioN/AN/A-
Revenue43.3M1.53M2,823%
Total Cash371M40.6M914%
Total Debt21.9M34.4M64%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTLYRA
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBHX44.47N/A
N/A
Rydex S&P MidCap 400 Pure Growth H
JCVWX22.91N/A
N/A
JHancock Classic Value R6
SREQX12.69N/A
N/A
PGIM Select Real Estate R6
OANLX75.97N/A
N/A
Oakmark Select Institutional
FGHMX97.70N/A
N/A
Fidelity Advisor Communication ServicesC

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-2.06%
LYRA - EYPT
58%
Loosely correlated
+18.59%
ATHE - EYPT
54%
Loosely correlated
-0.29%
OCUL - EYPT
53%
Loosely correlated
+0.98%
GLYC - EYPT
46%
Loosely correlated
-9.33%
MNMD - EYPT
45%
Loosely correlated
-0.94%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with GLYC. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then GLYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+18.59%
GLYC - LYRA
74%
Closely correlated
-9.33%
EYPT - LYRA
57%
Loosely correlated
-2.06%
SQZB - LYRA
29%
Poorly correlated
N/A
BCYC - LYRA
27%
Poorly correlated
-2.26%
ARVN - LYRA
26%
Poorly correlated
+1.74%
More